Drug interactions for the following drug(s)
Applies to: Cyclobenzaprine hydrochloride 5 MG Oral Tablet <> Trintellix (vortioxetine) 5 MG Oral Tablet
The risk or severity of CNS depression can be increased when Vortioxetine is combined with Cyclobenzaprine.
Applies to: CONCERTA 54 MG 24HR Extended Release Oral Tablet <> Trintellix (vortioxetine) 5 MG Oral Tablet
Methylphenidate may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Cyclobenzaprine hydrochloride 5 MG Oral Tablet <> Trintellix (vortioxetine) 5 MG Oral Tablet
Drug1 (rxcui = 828320, name = cyclobenzaprine hydrochloride 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1790892, name = vortioxetine 5 MG Oral Tablet [Trintellix], tty = SBD). Drug1 is resolved to cyclobenzaprine, Drug2 is resolved to vortioxetine and interaction asserted in DrugBank between Cyclobenzaprine and Vortioxetine.
Applies to: CONCERTA 54 MG 24HR Extended Release Oral Tablet <> Trintellix (vortioxetine) 5 MG Oral Tablet
Drug1 (rxcui = 1091212, name = 24 HR methylphenidate hydrochloride 54 MG Extended Release Oral Tablet [Concerta], tty = SBD). Drug2 (rxcui = 1790892, name = vortioxetine 5 MG Oral Tablet [Trintellix], tty = SBD). Drug1 is resolved to methylphenidate, Drug2 is resolved to vortioxetine and interaction asserted in DrugBank between Methylphenidate and Vortioxetine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.